Chagral Invest

Total investments

2

Average round size

7M

Portfolio companies

1

Follow on index

0.50

Areas of investment
Health CareMedical DeviceMedical

Summary

Among the most popular portfolio startups of the fund, we may highlight Endo Tools Therapeutics. Among the most successful fund investment fields, there are Health Care, Medical Device. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2019. The fund is constantly included in less than 2 deals per year.

The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, Epimu00e8de SA.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
0
Follow on index
0.50
Investments by industry
  • Medical (2)
  • Medical Device (2)
  • Health Care (2)
Investments by region
  • Belgium (2)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Endo Tools Therapeutics 11 Feb 2019 Health Care, Medical Device, Medical Late Stage Venture 5M Belgium, Hainaut, Charleroi
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.